@article{4e156f3f37c9428f97fb037001815b24,
title = "Anniversary reflections: ISSCR presidents on 20 years of progress",
abstract = "This year, Cell Stem Cell and the International Society for Stem Cell Research (ISSCR) are celebrating their 15th and 20th anniversaries, respectively. We took the opportunity to ask the current and four former ISSCR presidents to reflect on major stem cell advances during this time, the evolution of policy, clinical translation and ethical aspects, and future challenges for the field.",
author = "Melissa Little and Morrison, {Sean J.} and Janet Rossant and Deepak Srivastava and Daley, {George Q.}",
note = "Funding Information: S.J.M. is a founder and scientific advisory board member of Garuda Therapeutics and Kojin Therapeutics and a shareholder and former scientific advisory board member of G1 Therapeutics; serves on the scientific advisory boards of Frequency Therapeutics and ONA Therapeutics; and chairs the Public Policy Committee for the International Society for Stem Cell Research. M.L. S.J.M. J.R. D.S. and G.Q.D. are members of the Cell Stem Cell Advisory board. D.S. is a co-founder and member of the board of directors of Tenaya Therapeutics and has equity in Tenaya Therapeutics. G.Q.D. has filed invention disclosures and patents related to pluripotent stem cells and production of hematopoietic lineages, and he holds equity in and/or receives consulting fees from 28/7 Therapeutics and iTCells. Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",
year = "2022",
month = jun,
day = "2",
doi = "10.1016/j.stem.2022.05.003",
language = "English (US)",
volume = "29",
pages = "876--878",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "6",
}